RT @andrewkittle4: Who should $ACB select as its partner on the pharmaceutical front?
#PotStocks! #WeedStocks $PHE $CELG $JNJ $BMY
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @semodough: ISI data points in IMS data for first 2 full months of Q4 (Oct+Nov)
+ve $BMY IO franchise appears to be tracking well ahead…
$AGN, $BIIB and $BMY were among the companies that raised list prices, suggesting criticism hasn't halted a return… https://t.co/DVXp1dt9T9
$BMY:
FDA OKs expanded use for Bristol-Myers Squibb’s Sprycel:
https://t.co/V1LwxCiDYS
$BMY:
(dasatinib) Tablets Now Approved in Combination with …:
https://t.co/vfWPNNY0et
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
$BMY - FDA OKs expanded use for Bristol-Myers Squibb's Sprycel https://t.co/CiKh67qD2Q
$BMY Sprycel® (dasatinib) Tablets Now Approved in Combo with Chemo in Certain Pediatric Patients with Philadelphia… https://t.co/PEWWstJqeT
$BMY Bristol-Myers Squibb - Bristol-Myers Squibb’s Sprycel® (dasatinib) Tablets Now Approved in Combination w
From our Stock News Alerts App
Evening Most Tweeted Big Caps, check out Gambiste Top 10: $AGN $BA $T $D $STZ $BHP $CI $MO $BMY https://t.co/k3uyuEbRpJ
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
$BMY Sprycel dasatinib Tablets Now Approved in Combo with Chemo in Certain Pediatric Patients with Philadelphia Ch… https://t.co/KTOWTMd52H
$BMY Nivolumab + $NWBO DCVax-L Phase II trial originally planned to start approximately Jan 1 2019. I'm looking fo… https://t.co/xRMzOIeLHo
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
Rally $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS $UNH $VZ $KHC… https://t.co/hYuVJ1ScDX
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @crusadernz: Biotech updates 01/02:
$BMY Sprycel sBLA approval
$GNMX ADHD fail -71%
$MYOK -14% $SNY ends license
$SESN data tmrw
$PRAN…
RT @rago_carlo: $BMY Nivolumab + $NWBO DCVax-L Phase II trial originally planned to start approximately Jan 1 2019. I'm looking forward to…
RT @rago_carlo: $BMY Nivolumab + $NWBO DCVax-L Phase II trial originally planned to start approximately Jan 1 2019. I'm looking forward to…
RT @crusadernz: Biotech updates 01/02:
$BMY Sprycel sBLA approval
$GNMX ADHD fail -71%
$MYOK -14% $SNY ends license
$SESN data tmrw
$PRAN…
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @crusadernz: Biotech updates 01/02:
$BMY Sprycel sBLA approval
$GNMX ADHD fail -71%
$MYOK -14% $SNY ends license
$SESN data tmrw
$PRAN…
Biotech updates 01/02:
$BMY Sprycel sBLA approval
$GNMX ADHD fail -71%
$MYOK -14% $SNY ends license
$SESN data tmr… https://t.co/Fe8zBdZArL
$BMY: Bristol-Myers announces FDA expansion of indication for Sprycel https://t.co/ORBCgmawQl
$BMY Bristol-Myers Squibb Company Option Order Flow Sentiment has Turned from Bearish to Bullish. https://t.co/KFg9VOG0Cv
RT @crusadernz: Biotech updates 01/02:
$BMY Sprycel sBLA approval
$GNMX ADHD fail -71%
$MYOK -14% $SNY ends license
$SESN data tmrw
$PRAN…
RT @eWhispers: No #earnings this week (w/ analysts), so a look at Jan
$NFLX $BAC $BA $BBBY $KBH $SGH $STZ $MA $JPM $C $GS $JNJ $UNH $WFC $…
RT @rago_carlo: $BMY Nivolumab + $NWBO DCVax-L Phase II trial originally planned to start approximately Jan 1 2019. I'm looking forward to…
RT @rago_carlo: $BMY Nivolumab + $NWBO DCVax-L Phase II trial originally planned to start approximately Jan 1 2019. I'm looking forward to…
Price Moves vs Expected Moves $BHC $CGC $CELG $THC $TEVA $GILD $BMY $TLRY $PFE $JNJ $ABBV $AMRN https://t.co/T6y5z4l70A
Apple confirms investors' fear as their revenue falls. Watch video:
https://t.co/RluIdlB2QI
$JBLU $TWTR $SNAP… https://t.co/V4wqtaAQ4m
Apple confirms investors' fear as their revenue falls. Watch video:
https://t.co/RluIdlB2QI
$GBT $AAPL $BA $NVDA… https://t.co/hxFf6Dt403
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
Every Dark Cloud Has A Silver Lining_ZIOPHARM Oncology $ZIOP Will Confirm Acquisition Talks With Bristol-Myers Squi… https://t.co/kTIbtmYgfk
Emotional Roller Coaster_Namaste Technologies $NXTTF To Confirm Terms Of Agreement Reached in Significant Partnersh… https://t.co/x11kYuelyg
RT @AndyBiotech: Happy new year from drugmakers! Here comes the 1st wave of price hikes
$AGN
Linzess +9.5%
Restasis +9.5%
Viberzi +9.5%
Lu…
RT @rago_carlo: $BMY Nivolumab + $NWBO DCVax-L Phase II trial originally planned to start approximately Jan 1 2019. I'm looking forward to…
#earnings this month:
$NFLX $BAC $BA $BBBY $KBH $SGH $STZ $MA $JPM $C $GS $JNJ $UNH $WFC $AA $LRCX $CJPRY $SLB $ABT… https://t.co/0gcb8nSvqv
Brokerages Expect Bristol-Myers Squibb Co $BMY Will Announce Quarterly Sales of $5.99 Billion https://t.co/WKOBLJ8DDh
Ticker $BMY has Dividend today #Bullboard https://t.co/D0ynPMZ631
$5.99 Billion in Sales Expected for Bristol-Myers Squibb Co $BMY This Quarter https://t.co/4AfW9PmkyG #stocks
EPS for Hancock Whitney $HWC Expected At $1.13; Alexandria Capital Has Trimmed Its Bristol Myers Squibb Co Com $BMY… https://t.co/bPAtqxsKtT
Bristol-Myers: Has Fully Committed Debt Financing From Morgan Stanley, MUFG Bank >BMY $BMY $CELG $MS
$BMY - Bristol-Myers Squibb sees EPS as high as $3.85 this year https://t.co/LY2Seh60TV
RT @WallStJesus: Bristol-Myers Squibb to acquire Celgene for $74B https://t.co/DEuzFOpOz7 $BMY, $CELG https://t.co/eJgwxIraOI
BIOS today baby. $BIIB calls you better work ... $IBB $BMY $CELG https://t.co/Uoweem0D4Z
Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge 32% PM
$BMY $AGN $TEVA $PFE $AZN $SNY… https://t.co/CFfMEp7ZqS
Kinda a wash for me $BMY from gain to loss but $CELG loss to gain but $AAPL is going to hurt https://t.co/mQjbZOOHbF
$CELG up 30% premarket. $BMY https://t.co/TmqSPsoL4J
RT @BioStocks: $BMY ↓ 15% $CELG ↑ 30% PM
$BMY obvious bias being a celg long, but what a deal. Will look for a position here in 401k after this initial drop… https://t.co/j2PwWj3dMa
Bristol-Myers to buy Celgene for $74 billion https://t.co/mp8Gn22nGf $CELG $BMY
RT @Street_Insider: Bristol-Myers Squibb $BMY Reports Acquisition of Celgene Corp. $CELG for Approx. $74B https://t.co/Akt706otJs
$bmy wow talk about debt and dilution put on by $celg buyout
$CELG $BMY https://t.co/A0kAZLa4RO
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
RT @adamfeuerstein: $BMY buying $CELG — WOWZA!!!
$BMY buying $CELG for $74 billion
Today $CELG is out of the list, acquired by $BMY
Who's next? $SRPT $SAGE & $LOXO are the top candidats https://t.co/CLyoPEI4Ga
RT @adamfeuerstein: $BMY buying $CELG — WOWZA!!!
$bmy thats a way to say opdivo wont deliver
Huge news for $CELG this morning, being acquired by $BMY
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
RT @CGrantWSJ: Heard on the Street flagged $CELG as particularly cheap last week. Today, $BMY announces an acquisition. https://t.co/TqaBlu…
RT @fwpharma: BREAKING NEWS: Bristol-Myers Squibb to buy Celgene for around $74 billion https://t.co/muVctewK4t $BMY $CELG
RT @Street_Insider: Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/5yAUMONKax
RT @BiotechMoney18: $BMY buy $CELG for $74B deal. Wow!
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @Street_Insider: Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/5yAUMONKax
RT @theflynews: Bristol-Myers to acquire Celgene in deal with equity value of approx. $74B $BMY $CELG https://t.co/ujxLNrhYuD
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
Bristol-Myers Squibb to acquire Celgene for $74B $bmy $celg https://t.co/ScIk9rb6Bc #healthcare #merger
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
$BMY down 12.8% on announced deal to buy $CELG
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
Bristol-Myers to acquire Celgene in deal with equity value of approx. $74B $BMY $CELG https://t.co/ujxLNrhYuD
Bristol-Myers to pay $74B for Celgene
$BMY $CELG
https://t.co/0Lkhf7jf0o
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @DonnaYoungDC: Here's the PR: Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company https://t.co/uOYj…
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
First Blockbuster Deal of the Year:
$BMY ↓ 15% $CELG ↑ 30% https://t.co/RZmkcUfKXT
Wow!!! Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company https://t.co/gfQz7OrdCS $CELG, $BMY
#BristolMyers kauft #Celgene for 74 Milliarden Dollar! Celgene-Aktie springt um ein Drittel, $BMY sackt um über z… https://t.co/CoAMyZ4XYe
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @TheStreet: Breaking -- Bristol-Myers $BMY to Buy Celgene $CELG in Deal Valued at $74 Billion. More to follow on https://t.co/o6IinmgxZm
$bmy $celg deal will help with support to the #StockMarket https://t.co/yqusoCLmNO
RT @BioStocks: Cash and stock transaction with an equity value of approximately $74 billion. $BMY $CELG https://t.co/D0bzm3Nl0C
$CLVS who is going to buy this one? Any takers? Not $BMY
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
RT @BioStocks: $BMY Accelerated Share Repurchase of Up to About $5 Billion
Correction 80,000% so .02-16.00 or $200 into $155k overnight I don’t have any but someone’s waking up to two years… https://t.co/TH9j5KJxoB
Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/2QPxVMzwl4
RT @Street_Insider: Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/5yAUMONKax
Bristol-Myers To Purchase Celgene At $50/Share In Cash For ~$74B Deal $BMY https://t.co/m54DcBzywy @benzinga
$CELG knew they sucked and had to sell. I’ll give them props for that. I don’t think their pipeline is anything s… https://t.co/iISOHbOwYn
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @CGrantWSJ: Heard on the Street flagged $CELG as particularly cheap last week. Today, $BMY announces an acquisition. https://t.co/TqaBlu…
$celg $bmy lets hope its just the start https://t.co/UGfWOqqDOL
Bristol buying Celgene is a tacit admission they can’t deliver Opdivo. We’ve been buyers of CELG awaiting such a bid. $CELG $BMY.
$BMY Accelerated Share Repurchase of Up to About $5 Billion
RT @JPZaragoza1: At the right valuation deals get done. $BMY $CELG
For $BMY stock reaction (down 11% in pm) I guess the lack of visibility on revlimid IP is weighing $CELG
$CELG cash flow is significant.. if the merger can harvest that cash flow, it will be a good deal.. if not, then… https://t.co/cHfgMYkFkb
RT @JacobPlieth: 2018 stock performances: $BMY -15%. $CELG -39%. Sure, why not? https://t.co/h1pPRhFwpc
RT @Street_Insider: Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/5yAUMONKax
RT @BioStocks: $BMY ↓ 15% $CELG ↑ 30% PM
RT @_B_I_O_T_E_C_H_: $BMY just emerged as a new $SGMO suitor
re allogeneic CAR-T , re Alzheimer Re $CELG Celgene zinc finger research ... h…
Huge news: $BMY buying $CELG for $74bn. Combined company will have 9 products with over $1bn in revenues. https://t.co/wvTKqftet4
$BMY loves their IP issues!
-Pembro royalty
-Eliquis ANDA blocking
-Orencia
And now
-Revlimid!
$BMY $CELG Jeez, sports https://t.co/zwTMUTYssV
RT @gualestrit: $BMY -12% pre-market
$CELG +32% pre-market https://t.co/YLUcvwjMPT
DAMMMOFF BY A DAY $CELG $BMY https://t.co/AJlpp7iChZ
$BMY just emerged as a new $SGMO suitor
re allogeneic CAR-T , re Alzheimer Re $CELG Celgene zinc finger research ... https://t.co/JjUG4PrKuW
@BursatilBiotech @Sports_bios Well, good call on $CELG + $BMY.
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
RT @jonathanrockoff: $BMY has agreed to buy $CELG for $74bn
Bristol-Myers to buy Celgene in a $74 billion deal.
$BMY
RT @BioStocks: $BMY ↓ 15% $CELG ↑ 30% PM
RT @Street_Insider: Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/5yAUMONKax
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
$BMY ↓ 15% $CELG ↑ 30% PM
RT @Street_Insider: Bristol-Myers Squibb $BMY Reports Acquisition of Celgene Corp. $CELG for Approx. $74B https://t.co/Akt706otJs
$BMY buy $CELG for $74B deal. Wow!
$BMY you gotta be kidding me https://t.co/sQYm5kFTb3
$BMY (-14% pre-market) buying $CELG (+29% pre-market) https://t.co/dA29SBYJ61 https://t.co/3rmBxn0Znp
One of our favorite stocks $CELG up 30% pre-market on news that $BMY is acquiring them.
Bristol-Myers Squibb $BMY falls 12.2% after announcing acquisition of Celgene Corporation $CELG https://t.co/5yAUMONKax
Day 3 of 2019: Bristol-Myers casually buying Celgene in ~$74b (EV) deal. $CELG holders getting 1 $BMY share and $50… https://t.co/OGWmA6kPgW
Heard on the Street flagged $CELG as particularly cheap last week. Today, $BMY announces an acquisition. https://t.co/TqaBluSyeG
$BMY Wow! Finally someone taking out $CELG. Looks to be a bit of a steal all things considered. At least the nightm… https://t.co/AgWJI3WjM7
RT @gualestrit: $BMY -12% pre-market
$CELG +32% pre-market https://t.co/YLUcvwjMPT
RT @semodough: FIRST thing that crosses my mind with $BMY $CELG deal is there others. Imho seems $BMY got a dang good deal -possibly bes…
$CELG HOLY FLOCK up $BMY to buy https://t.co/WqatSF3nXZ
Bristol Myers Squibb Sees 2019 Adj EPS Range At $4.10-$4.20 (est $4.10) $BMY
-Sees 2019 GAAP EPS Range At $3.75-$3… https://t.co/NxszQ4vwiW
@NotaBubble @VendbienJon @7wtc @daesr1 @yusschr @marc_slans Bristol-Myers--to-BUY-Celgene
$CELG
$BMY
Great-deal-t… https://t.co/jUjgEuiANT
Bristol-Myers Squibb to acquire Celgene for $74B https://t.co/DEuzFOpOz7 $BMY, $CELG https://t.co/eJgwxIraOI
$BMY -12% pre-market
$CELG +32% pre-market https://t.co/YLUcvwjMPT
Bristol-Myers Squibb in $74-billion stock-and-cash deal for Celgene. Details soon $BMY $CELG
RT @fwpharma: BREAKING NEWS: Bristol-Myers Squibb to buy Celgene for around $74 billion https://t.co/muVctewK4t $BMY $CELG
Wow! $CELG up over 30% on $BMY acquisition! Was eyeing this one yesterday... #noposition
Merger.. whatever today is .. Thursday $CELG $BMY
FIRST thing that crosses my mind with $BMY $CELG deal is there others. Imho seems $BMY got a dang good deal -pos… https://t.co/WqRMiq9D7J
@JPZaragoza1 $CELG's pipeline in the hands of a management team that actually knows what it is doing ( $BMY ), plus… https://t.co/JKxPzog1DV
RT @JacobPlieth: 2018 stock performances: $BMY -15%. $CELG -39%. Sure, why not? https://t.co/h1pPRhFwpc
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @adamfeuerstein: $BMY buying $CELG — WOWZA!!!
RT @JohnCendpts: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/gl…
RT @Clay1016: #Breaking — Bristol-Myers and Celgene to Merge in $74 Billion Equity Value Deal $BMY $CELG https://t.co/asnKPictsz
RT @JohnCendpts: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/gl…
RT @JohnCendpts: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/gl…
If $CELG is so great and their pipeline is so special why is $BMY selling off.
RT @LiveSquawk: Bristol Myers Squibb To Buy Celgene To Create A Premier Innovative BioPharma Company $CELG $BMY
-Deals For Approx $74Bln, $…
Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/glLgaax4WU
Who will step up and say not enough Money ? to $BMY $CELG
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
#Breaking — Bristol-Myers and Celgene to Merge in $74 Billion Equity Value Deal $BMY $CELG https://t.co/asnKPictsz
$BMY $CELG - Bristol-Myers Squibb to acquire Celgene for $74B https://t.co/4R9BI2fqqA
Sorry $BAC, you got left out!
$BMY $CELG https://t.co/61BR7i3ydP
$BMY to buy $CELG in a $74 billion deal.
RT @TheStreet: Following deal, stocks make big moves premarket:
- $BMY down 14.55%
- $CELG up 31.08%
Wow- $BMY to Acquire $CELG to Create a Premier Innovative Biopharma Company #MnA | Business Wire https://t.co/miAj8g5wOl
RT @TheStreet: Breaking -- Bristol-Myers $BMY to Buy Celgene $CELG in Deal Valued at $74 Billion. More to follow on https://t.co/o6IinmgxZm
$BMY $CELG - Bristol-Myers Squibb to acquire Celgene for $74B https://t.co/kvSwHHMKCj https://t.co/OtlyaE5NWM
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
@VendbienJon @NotaBubble @daesr1 @7wtc @marc_slans @yusschr
$BMY-dropping-like-a-Rock
The-deal-is-cash-AND-stock… https://t.co/ONKOyii27R
RT @TheStreet: Following deal, stocks make big moves premarket:
- $BMY down 14.55%
- $CELG up 31.08%
RT @TheStreet: Breaking -- Bristol-Myers $BMY to Buy Celgene $CELG in Deal Valued at $74 Billion. More to follow on https://t.co/o6IinmgxZm
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
$BMY $CELG:
Bristol-Myers Squibb to acquire Celgene for $74B:
https://t.co/I57eftNOQJ
$BMY $CELG:
Bristol-Myers Squibb to Acquire Celgene to Create a Premier …:
https://t.co/j7RbUHpMht
Following deal, stocks make big moves premarket:
- $BMY down 14.55%
- $CELG up 31.08%
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
بريستول باير الطبية $BMY تستحوذ على سيلجن $CELG ب 74 مليار دولار لتكوّن أكبر شركة طبية
$BMY $CELG CELGENE SAYS $33.5 BLN FULLY UNDERWRITTEN BRIDGE FACILITY OBTAINED FROM MORGAN STANLEY AND MUFG FOR FI… https://t.co/RlZURZECCR
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
WOW...CNBC reporting that Bristol-Myers Squibb to acquire Celgene for $74 bil $CELG $BMY #biotech #biotechstocks
RT @jonathanrockoff: $BMY has agreed to buy $CELG for $74bn
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
$CELG-$107?
No,
1-$BMY-share+50-cash=$96-97
folks
@SquawkStreet
@SquawkCNBC
Anti-PD-(L)1 drugs approved in Japan $MRK $BMY $AZN $PFE $MKGAF https://t.co/4OUR2u8a5g
BMO $MRK $BMY QVIA November 2018 U.S. sales were released. U.S. IO market continuing strong growth: Rolling 12-mont… https://t.co/pObwwYW0yd
$GILD $IBB sympathy play on $CELG / $BMY deal this morning
RT @wboscoho: @LaMonicaBuzz $BMY buying $CELG is brilliant tho since the latter has investments in so many biotech juniors.
Suddenly, $GIL…
RT @wboscoho: @LaMonicaBuzz $BMY buying $CELG is brilliant tho since the latter has investments in so many biotech juniors.
Suddenly, $GIL…
@LaMonicaBuzz $BMY buying $CELG is brilliant tho since the latter has investments in so many biotech juniors.
Sudd… https://t.co/yoCAN6C9kR
Just like $IBM buying redhat , when $BMY acquires $CELG
Laggards: $BMY $AAPL $SWKS $BBY $OLED $AVGO https://t.co/uRdviuAi02
Stocks Making Moves PM: $AAPL $CELG $BMY $SWKS $QRVO $AVGO $OLED $JNJ $UBS $TEVA $AMGN $TRCO $JWN $HUM $LITE & More https://t.co/yB1ifU9OBD
RT @Hotpage_News: Stocks making the biggest moves premarket: $AAPL $BMY $CELG $OLED $LITE $AVGO $QRVO $SWKS $JNJ $DBK $UBS $AMGN $TEVA $CH…
Stocks making the biggest moves premarket: $AAPL $BMY $CELG $OLED $LITE $AVGO $QRVO $SWKS $JNJ $DBK $UBS $AMGN… https://t.co/SSmjsMCTpu
RT @adamfeuerstein: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/T4ILLgj5Xh $BMY $CELG and first co-byli…
RT @JohnCendpts: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/gl…
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
$CELG $BMY, makes $BMY an even tastier target for large cap pharma.
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
Bonkers recovery in #ES_F spot 2487, $BMY buyout of $CELG helped, $AAPL largely a non event? https://t.co/fMu7O3ClzL
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
Note: BofA was not a bank on the $BMY $CELG deal. https://t.co/qs6xcO2n50
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
$CELG call going well, I think its a great deal for both companies and $BMY will recover from arbitrageurs shorting shares to put on spread.
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
So I wrote this over the last couple of weeks and it finally went to print almost exactly when the $BMY and $CELG n… https://t.co/SjcGdKyZCN
RT @StockAcademy: #ICYMI on @business Daybreak:
-Tech: $APPL revised Q1 revenue guidance to $84B
-Healthcare: $BMY to buy $CELG in $74B…
At $74bn, $BMY/ $CELG deal is the fourth-largest #biopharma acquisition to date, behind Glaxo/SmithKline, Takeda/Sh… https://t.co/2ULSviSZYP
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
RT @adamfeuerstein: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/T4ILLgj5Xh $BMY $CELG and first co-byli…
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @adamfeuerstein: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/T4ILLgj5Xh $BMY $CELG and first co-byli…
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
RT @adamfeuerstein: $BMY buying $CELG — WOWZA!!!
RT @AndyBiotech: $BMY + $CELG decent synergy and complementary portfolio, now #2 Oncology company closely behind Roche with a better odds f…
RT @BerkeleyJr: $CELG up 32% in premarket after $BMY agreed to buy it for $74 billion https://t.co/pKRV8FrtC7
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
Big deal: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/3hk99xQQsv $BMY $CELG. https://t.co/3hk99xQQsv
This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @Palino: Bristol-Myers Squibb to acquire Celgene for $74B https://t.co/1aD5oJaTyo $BMY, $CELG
Mixed feelings about $CELG going away with $BMY acquisition. They started out as nimble and innovative and had a hu… https://t.co/DeVHpi4kNG
$BMY expects >45B in FCF over 1st 3yrs of $CELG deal
RT @adamfeuerstein: $BMY buying $CELG — WOWZA!!!
RT @JacobPlieth: $74bn makes $BMY $CELG the fourth-biggest pharma megamerger. Via @EdwinElmhirst https://t.co/UQWAscAwqA
RT @coryrenauer: I'm going to need help deciding what to call the new $BMY plus $CELG Pick your favorite:
RT @adamfeuerstein: $BMY buying $CELG — WOWZA!!!
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
$BMY + $CELG decent synergy and complementary portfolio, now #2 Oncology company closely behind Roche with a better… https://t.co/yWgueqHesh
#premarket #january03 #ATTENTION #HIGH #VOLUME #SPECIAL IN $AAPL $BMY $CELG https://t.co/Qy717IK88P
Biotech M&A With a Strong Start in 2019: More Deals to Follow?
$BMY & $CELG for $74B .... larger than all 16 M&A i… https://t.co/GYyWRexdcb
RT @ArabicWallSt: بريستول باير الطبية $BMY تستحوذ على سيلجن $CELG ب 74 مليار دولار لتكوّن أكبر شركة طبية
$BMY to buy $CELG, giving pharma M&A a big boost at the start of the year- https://t.co/AP08JU38oA
$CELG take out px = px of $BMY + $50
congrats to $CELG holders! https://t.co/UC6veH94IL
Bristol-Myers Squibb Bets Big On Celgene In $74B Cash And Stock Deal https://t.co/WVDh8dnbp7 $BMY $CELG
#Drug channel impact? @bmsnews $BMY to acquire @Celgene $CELG ( https://t.co/In6hFGHyma ). Note Celgene channel ap… https://t.co/09yGUByEO4
$BMY to acquire $CELG in a cash and stock transaction valued at approx. $74B https://t.co/QUHIvzU5aD
RT @LTbioinvestor: The mega $bmy $celg deal is good for
$celg $bmy Massive acquisition but not necessarily reflected in offering price. Celgene still while off ATH's. Will… https://t.co/UIuurUXpZO
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
RT @LiveSquawk: Bristol Myers Squibb To Buy Celgene To Create A Premier Innovative BioPharma Company $CELG $BMY
-Deals For Approx $74Bln, $…
RT @The_Real_Fly: Celgene to be acquired by Bristol-Myers Squibb (BMY) for $102.43/share in cash & stock + a CVR, or approximately $74 bln…
RT @OptionsHawk: Will be away most of today, but what a blockbuster M&A deal with $CELG $BMY to kick off 2019 , started to see flows two we…
RT @JohnCendpts: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/gl…
$BMY acquiring $CELG ... amazing
$BMY $CELG my head exploded and for the past 30 minutes I can't process this. This is THE most unlikely and oddest… https://t.co/cbVQKGiIRS
I'm going to need help deciding what to call the new $BMY plus $CELG Pick your favorite:
RT @cbtadvisors: $CELG up 30% to $87, $BMY down 15% to $44! UPDATED: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year…
Will be away most of today, but what a blockbuster M&A deal with $CELG $BMY to kick off 2019 , started to see flows… https://t.co/vKhqlGFGEW
RT @TheStreet: Breaking -- Bristol-Myers $BMY to Buy Celgene $CELG in Deal Valued at $74 Billion. More to follow on https://t.co/o6IinmgxZm
RT @odibro: $BMY to Acquire $CELG in a cash and stock transaction with an equity value of approximately $74B https://t.co/DxZnEc5shl
RT @JohnCendpts: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/gl…
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
$BMY (Bristol-Myers Squibb) plans to buy Celgene in cash/stock deal worth $74B
$CELG up 33% or $22 from $66/share… https://t.co/ThdzL9SBOE
Biggest Losers in #Premarket Trading $BMY $STM $AAPL $SOXL $TQQQ $SPXL $QLD $GUSH $UPRO $MU $NVDA $AMD $ROKU https://t.co/sNm3XHVbGw
#TRADING US PM Gaps $SESN $BMY $STM $AAPL $MU $NVDA $ROKU $AMD $APHA $QCOM $INTC $TSLA $NFLX $MSFT $GE $AMZN $BIDU… https://t.co/E3nz5B9mKa
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE… https://t.co/1xNWCYTWwp
with $celg deal, $mrk keytruda battle vs $bmy opdivo battle gets a lot more interesting
The $BMY $CELG deal creates a top-ten pharma co, ranking alongside giants like $GSK and $MRK by revenue. https://t.co/xZ7Q4bflvj via @WSJ
#Premarket Watches
$CELG $BMY $ALQA $AAPL $CRUS $SWKS
Pre-market tickers on watch: $GILD $DBVT $PTLA $BMY $TSLA $SWKS
Pre-market breakdown everyday 8-9:30am EST. Break… https://t.co/sKWSUCY313
A Peek Into The Markets: US Stock Futures Drop, Apple Cuts Q1 Sales Guidance
$USO $AAPL $CELG $OHRP $ANTM $SPY… https://t.co/7YYQ07pLJ5
RT @adamfeuerstein: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/T4ILLgj5Xh $BMY $CELG and first co-byli…
RT @lisamjarvis: Looks like the slides are up for the $BMY/Celgene call. Here's the part the scientists at both companies will care about.…
Lightning fast recap of the morning premarket movers! Come and take it. https://t.co/3RdvyWRaNM . $AAPL $LITE… https://t.co/2fm78VYSXJ
RT @JPZaragoza1: At the right valuation deals get done. $BMY $CELG
Order Imbalance Strategy $SBS +4400 $AZN -400 $BMY +6000 $BBY -3600
RT @JacobPlieth: $74bn makes $BMY $CELG the fourth-biggest pharma megamerger. Via @EdwinElmhirst https://t.co/UQWAscAwqA
RT @davidfaber: Some background on Celgene/ Bristol: Been talking since Sept. when $BMY approached. Established price range in fall and pro…
$CELG to be taken over by $BMY here's what you need to know! https://t.co/yS7H1ZgoZt
RT @TheStreet: Breaking -- Bristol-Myers $BMY to Buy Celgene $CELG in Deal Valued at $74 Billion. More to follow on https://t.co/o6IinmgxZm
$BMY i see this acq as real bad. acq something at 1.5x prem w no str benefits to justify it. am biased shrt but som… https://t.co/YjMKOQXsO8
Some background on Celgene/ Bristol: Been talking since Sept. when $BMY approached. Established price range in fall… https://t.co/vvjQZ2xPRp
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
@ByMadeleineA @evaluatepharma Typically 2/3 of these types of mergers fail & share price reactions bear that out… https://t.co/9JOLQ5pfkp
Bristol-Myers looking like it overdosed on Sal Hepatica.
$BMY -12% pre-market.
Missed the $CELG buy I bought $BMY and $MBRX
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
Who is going to buy $CLVS now.
? I thought $BMY was one with better suited to acquire it. Man!!! It might be tough… https://t.co/PZOuuAL37g
"Bristol-Myers Squibb buying Celgene in $74B deal" --Associated Press 1/3/2019 $BMY $CELG #buyout #acquisition
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
$CELG CC-90002 anti CD47 Antibody-ST-001 is open-label, P1 dose escalation/expansion 1st in human clinical study of… https://t.co/PL8KC0uCZg
RT @Lybsoo: $BMY rachète Celgene pour 74 milliards ! 2019 est dorénavant lancée ... #Fusaq
https://t.co/wza0MTAXyc
RT @semodough: $BMY $CELG Strong Combined Cash Flows, Enhanced Margins and EPS Accretion of Greater Than 40% in First Full Year
Approximate…
RT @_B_I_O_T_E_C_H_: $BMY just emerged as a new $SGMO suitor
re allogeneic CAR-T , re Alzheimer Re $CELG Celgene zinc finger research ... h…
$CELG has been sold to $BMY for x8 2020 EPS
With any stretch of imagination how can this be good for @Celgene shareholders?
RT @AndyBiotech: $BMY + $CELG decent synergy and complementary portfolio, now #2 Oncology company closely behind Roche with a better odds f…
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
$BMY $CELG
Bristol-Myers beefs up cancer portfolio with $74 billion Celgene buy https://t.co/U7OediQn05
After $CELG junk, $BMY face saving exercise https://t.co/CFPUGXg3dA
RT @AndyBiotech: On the dark side, $BMY + $CELG mega deal not such a good news for small bios as $XBI losing its most generous buyer EVER..…
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
RT @JohnCendpts: UPDATED: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https:…
RT @Jessicaemerrill: Merged $BMY & $CELG would be the seventh biggest biopharma in the world, based on 2017 pharma revenues, behind $PFE, $…
Table of Recent Biotech Buyouts and Premiums (updated4 $BMY- $CELG):
https://t.co/WsrNdqMzua
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
RT @bio_clouseau: $CELG $BMY slides https://t.co/r3Q53g2yz0
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
RT @semodough: $BMY $CELG pipeline and launches https://t.co/uB7dsKTDtf
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
RT @JacobPlieth: Last May @ByAmyBrown wrote this about $CELG https://t.co/2ciFZS9iSS The stock fell another 16% before $BMY did the deal.
UPDATED: Bristol-Myers inks a $74B deal to buy out Celgene, expects $15B a year from late-stage pipeline
$BMY $CELG
https://t.co/glLgaax4WU
RT @alifarhat79: $bmy making an offer to acquire $celg for $74b with the cost of debt rising :
@StockCats @SJosephBurns @Hipster_Trader @M…
Is $loxo next for $bmy post $celg news?
RT @Mahek_MD: Big deal: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/3hk99xQQsv $BMY $CELG. https://t.c…
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
On the dark side, $BMY + $CELG mega deal not such a good news for small bios as $XBI losing its most generous buyer EVER....
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company $BMY $CELG https://t.co/CTIf7DSkLN
$CELG down from over $100 was $65 now $BMY makes a bid to buy them back to $88 how many investors bailed or w… https://t.co/smUqv8Cf4c
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
Keeping with tradition — of course this happens while I’m on maternity leave! $BMY $CELG https://t.co/XeAeN3MtgL
RT @adamfeuerstein: Bristol-Myers Squibb will acquire Celgene in blockbuster $74B deal https://t.co/T4ILLgj5Xh $BMY $CELG and first co-byli…
RT @amandamicklus: At $74bn, $BMY/ $CELG deal is the fourth-largest #biopharma acquisition to date, behind Glaxo/SmithKline, Takeda/Shire,…
$BMY $CELG - trending on twitter on this morning
RT @BioStocks: $BMY *Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company. $CELG
Bristol-Myers Squibb $BMY Issues FY 2019 Earnings Guidance https://t.co/nWWoOvJMpo #stocks
RT @gcbioinv: Leerink saying $CELG holders should take the $ and run, sell now and don't risk $BMY holders voting down the bid based on AM…
@DavidSchawel BAML: Pharma mega M&A 'unlikely' in 2019
$BMY and $CELG be like: https://t.co/IqDAfVMIkj
Streaming alerts, Live chat, Pre-Mkt, After-Mkt, Bear scan for active traders $AAPL $CELG $BMY $XBI… https://t.co/jb0NrskBqM
@fezziwig2008 looks like this whole time $BMY was eyeing $CELG.... $HALO is still a forgotten fly no one cares about.
RT @kristen_hallam: $BMY to buy $CELG, giving pharma M&A a big boost at the start of the year- https://t.co/AP08JU38oA
Bristol-Myers Squibb $BMY Issues FY 2019 Earnings Guidance https://t.co/p6bEGryD8I
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
MergerBrief Daily
$CELG $BMY Brief Posted
$CVON Possible CFIUS and TO Expiration
https://t.co/CakWyJRov5 #merger #mergerbrief
Bristol-Myers Squibb $BMY Releases FY 2019 Earnings Guidance https://t.co/PRWriPqhB3
RT @LifeSciVC: Mega-deal $BMY & $CELG: good news for more big cap M&A speculation, but bad news for private & small-cap names as consolidat…
This is going to help drug prices tremendously. We aren’t going to be able to afford anything! $BMY
RT @DavidSchawel: This analyst’s 2019 prediction lasted only 30 minutes before $BMY $CELG set a new record https://t.co/tnAUMBSOz8
$BMY Reveals full-year 2019 EPS outlook https://t.co/qmYKEb5USI
$BMY shareholders got shafted big time. Now revlimid is your problem. $BMY is dead money now.
RT @AndyBiotech: $BMY + $CELG decent synergy and complementary portfolio, now #2 Oncology company closely behind Roche with a better odds f…
RT @JacobPlieth: $74bn makes $BMY $CELG the fourth-biggest pharma megamerger. Via @EdwinElmhirst https://t.co/UQWAscAwqA
RT @RiskArbCandriam: Bristol Myers Squibb will acquire Celgene for $74Bn. $CEL shareholders will receive 1 share of $BMY and $50 per share…
In OM:
$CELG gained >32%
$BMY declined >12% https://t.co/hbGKpUTI7Y
Last May @ByAmyBrown wrote this about $CELG https://t.co/2ciFZS9iSS The stock fell another 16% before $BMY did the deal.
$celg $bmy a 50%+ control premium AND another ~15% in a cvr should tell you that large cap biowreck has gotten too… https://t.co/PeaZlFrkQN
RT @GideonGil: Mega deal gives $BMY access to experimental cell therapies, expanding its cancer franchise https://t.co/J9VcOkyowH via @sta…
Top losers 8:22am:
$SESN -22% 675k Vol 49M Flt
$BMY -12% 3.3M Vol 1.63B Flt
$CCCL -12% 34k Vol 3.6M Flt
$STM -9% 109M Vol 911M Flt
$SPY
$BMY 45.23 -7.20 (-13.73%) + $50 LESS some arb = $90 for the time unless BMY goes highhhherrrrrrrrr........
RT @gcbioinv: $BMY loves their IP issues!
-Pembro royalty
-Eliquis ANDA blocking
-Orencia
And now
-Revlimid!
Popular: $AAPL, $CELG, $BMY, $IBB, $INCY, $RES, $MPX, $TEVA, $FSLR, $CSIQ, $VUZI, $SMPL, $LABU, $MOH, $CI, $VRCA, $VCYT
So compelling $BMY shares are called down 12%!
Still their largesse has helped goose up $GILD 3%+ pre-market
(an… https://t.co/SzoRXcqhP1
RT @OpenOutcrier: $GILD (+3.4% pre) Gilead Sciences (GILD) Gains 3.2% Following BMY/CELG Deal $BMY $CELG - SI
https://t.co/wJyDjXedhY
$GILD (+3.4% pre) Gilead Sciences (GILD) Gains 3.2% Following BMY/CELG Deal $BMY $CELG - SI
https://t.co/wJyDjXedhY
#ICYMI on @business Daybreak:
-Tech: $APPL revised Q1 revenue guidance to $84B
-Healthcare: $BMY to buy $CELG in… https://t.co/7r3UlnesGP
RT @fklivestolearn: StocksToWatch: $AAPL, $CELG, $JNJ, $UBS, $TEVA, $AMGN, $TRCO, $JWN, $HUM, $DBVT, $SBS, $BMY, $STM, $OAS, $CRUS, $LITE,…
StocksToWatch: $AAPL, $CELG, $JNJ, $UBS, $TEVA, $AMGN, $TRCO, $JWN, $HUM, $DBVT, $SBS, $BMY, $STM, $OAS, $CRUS,… https://t.co/0RVHZp1iPm
Long Watches: $HRTX, $CELG, $GILD, $FSLR, $DBVT, $MRNA, $MYL! Short Watches: $AAPL, $AVGO, $MLNX, $BMY, $ADP, $QCOM!